Latest Impact Factor: Latest Impact Factor: 6.568
The Official Journal of: American Thyroid Association®
Read and share these online ahead-of-print articles with free access through April 6, 2022.
Redifferentiating Effect of Larotrectinib in NTRK-Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer
Lionel Groussin, Hélène Theodon, Laura Bessiene, Leopoldine Bricaire, Fidéline Bonnet-Serrano, Béatrix Cochand-Priollet, Karen Leroy, Simon Garinet, Eric Pasmant, Jérémie Zerbit, Romain Seban, François Goldwasser, Jérôme Clerc, Anne Segolene Cottereau, and Olivier Huillard
Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review
Roger Chou, Tracy Dana, Megan Haymart, Angela M. Leung, Ralph P. Tufano, Julie Ann Sosa, and Matthew D. Ringel
Trends in the Management of Localized Papillary Thyroid Carcinoma in the United States (2000–2018)
Elisa Pasqual, Julie Ann Sosa, Yingxi Chen, Sara J. Schonfeld, Amy Berrington de González, and Cari M. Kitahara
Levothyroxine for the Treatment of Subclinical Hypothyroidism in Thyroperoxidase Antibody Negative Pregnant Women: The Jury Is Still Out
Elizabeth N. Pearce, Tim I.M. Korevaar, and Angela M. Leung
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.